Literature DB >> 15609761

Stinging and biting insect allergy: an Australian experience.

Graham O Solley1.   

Abstract

BACKGROUND: Stings and bites from various insects are responsible for many anaphylactic events.
OBJECTIVE: To document the clinical features of specific forms of anaphylaxis and investigate clinical concerns regarding stinging and biting insect allergy.
METHODS: All patients presenting for evaluation of adverse reactions to insect stings or bites between December 1980 and December 1997 had the clinical details of their reactions recorded and their reactions classified.
RESULTS: The spectrum of clinical symptoms and signs is similar to that seen in anaphylaxis from other sources; stings on the head or neck are not more likely to cause life-threatening reactions than stings elsewhere on the body; a lesser reaction will not necessarily lead to a more serious reaction from a future sting; asthmatic patients do appear to have an increased risk of asthma as a feature of their anaphylactic response; anaphylaxis is usually confined to a particular insect species for the individual patient; patients who have had multiple stings at one time may have experienced true anaphylaxis and not a "toxic" response; and patients who have had anaphylaxis from other sources are at no greater risk than that of the general population of reacting similarly to insect stings or bites.
CONCLUSIONS: Anaphylactic events from insect stings show the same clinical features as those from other sources. Systemic reactions seem confined to a specific insect species. Patients who experience RXN3 reactions from multiple stings at one time should undergo specific venom testing, because many have experienced true anaphylaxis and not a toxic response. Future consideration should be given to the role of beta-adrenergic antagonists and ACE inhibitors in patients with systemic reactions.

Entities:  

Mesh:

Year:  2004        PMID: 15609761     DOI: 10.1016/S1081-1206(10)61259-8

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  6 in total

1.  Multiple epinephrine doses for stinging insect hypersensitivity reactions treated in the emergency department.

Authors:  Susan A Rudders; Aleena Banerji; Daniel P Katzman; Sunday Clark; Carlos A Camargo
Journal:  Ann Allergy Asthma Immunol       Date:  2010-07       Impact factor: 6.347

2.  Risk factors in Hymenoptera venom allergy.

Authors:  F Ruëff; J Kroth; B Przybilla
Journal:  Allergol Select       Date:  2017-08-04

3.  Comorbidities and Cofactors of Anaphylaxis in Patients with Moderate to Severe Anaphylaxis. Analysis of Data from the Anaphylaxis Registry for West Pomerania Province, Poland.

Authors:  Iwona Poziomkowska-Gęsicka; Magdalena Kostrzewska; Michał Kurek
Journal:  Int J Environ Res Public Health       Date:  2021-01-05       Impact factor: 3.390

Review 4.  Global View on Ant Venom Allergy: from Allergenic Components to Clinical Management.

Authors:  Troy Wanandy; Emily Mulcahy; Wun Yee Lau; Simon G A Brown; Michael D Wiese
Journal:  Clin Rev Allergy Immunol       Date:  2021-06-01       Impact factor: 8.667

5.  Clinical effectiveness of hymenoptera venom immunotherapy: a prospective observational multicenter study of the European academy of allergology and clinical immunology interest group on insect venom hypersensitivity.

Authors:  Franziska Ruëff; Bernhard Przybilla; Maria Beatrice Biló; Ulrich Müller; Fabian Scheipl; Michael J Seitz; Werner Aberer; Anna Bodzenta-Lukaszyk; Floriano Bonifazi; Paolo Campi; Ulf Darsow; Gabrielle Haeberli; Thomas Hawranek; Helmut Küchenhoff; Roland Lang; Oliviero Quercia; Norbert Reider; Peter Schmid-Grendelmeier; Maurizio Severino; Gunter Johannes Sturm; Regina Treudler; Brunello Wüthrich
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

6.  Current state of follow-up care for patients with Hymenoptera venom anaphylaxis in southwest Germany: Major impact of early information.

Authors:  Manisha Manmohan; Sabine Müller; Michèle Myriam Rauber; Frank Koberne; H Reisch; Joachim Koster; Richard Böhm; Martin Messelken; Matthias Fischer; Thilo Jakob
Journal:  Allergo J Int       Date:  2018-01-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.